Here are what the editors at HealthDay consider to be the most important developments in Pain Management for June 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
MSSP ACOs May Not Improve Spending, Quality of Care
WEDNESDAY, June 26, 2019 (HealthDay News) — After adjustment for the nonrandom exit of clinicians, the Medicare Shared Savings Program (MSSP) is not associated with improvements in spending or quality, according to a study published online June 18 in the Annals of Internal Medicine.
Americans Concerned About Clinician Burnout
WEDNESDAY, June 26, 2019 (HealthDay News) — Nearly three-quarters of Americans are concerned about burnout among their clinicians, according to a survey released June 17 by the American Society of Health-System Pharmacists (ASHP).
Cancer Survivors Have High Prevalence of Chronic Pain
TUESDAY, June 25, 2019 (HealthDay News) — Cancer survivors have a high prevalence of chronic pain, according to a research letter published online June 20 in JAMA Oncology.
New England Journal of Medicine Picks New Editor-in-Chief
THURSDAY, June 20, 2019 (HealthDay News) — The new editor-in-chief of the prestigious New England Journal of Medicine is Eric J. Rubin, M.D., Ph.D., who was selected after a worldwide search and plans to start in September, according to the Massachusetts Medical Society, which publishes the journal.
Health Care Workers With ARIs Often Work While Symptomatic
THURSDAY, June 20, 2019 (HealthDay News) — Almost all health care workers (HCWs) with acute respiratory illness (ARI) report working at least one day while symptomatic, according to a study published online June 18 in Infection Control & Hospital Epidemiology.
Patterns of Inpatient Opioid Use Linked to Long-Term Use
TUESDAY, June 18, 2019 (HealthDay News) — Specific patterns of opioid administration to opioid-naive inpatients are associated with risk for long-term use after discharge, according to a study published online June 18 in the Annals of Internal Medicine.
Drug Makers Challenge New Rule Requiring Drug Prices in TV Ads
MONDAY, June 17, 2019 (HealthDay News) — Three large drug makers have launched a legal challenge against the Trump administration’s rule requiring the prices of drugs to be included in television ads.
Maine Legalizes Assisted Suicide
FRIDAY, June 14, 2019 (HealthDay News) — Maine has become the eighth state to legalize medically assisted suicide.
Opioid-Sparing Strategy Still Provides Good Pain Control
FRIDAY, June 14, 2019 (HealthDay News) — Following implementation of an opioid-sparing pain management strategy, half of patients report using no opioids and adequate pain control, according to a study published online May 30 in the Journal of the American College of Surgeons.
Long-Term Opioid Prescribing Up Among Older Cancer Survivors
THURSDAY, June 13, 2019 (HealthDay News) — The rates of prolonged opioid prescribing remain high for older cancer survivors five or more years after cancer diagnosis, according to a study published in the May issue of the Journal of the American Geriatrics Society.
Gabapentinoids Linked to Increased Risk for Significant Adverse Outcomes
THURSDAY, June 13, 2019 (HealthDay News) — Gabapentinoids are associated with increased risks for adverse outcomes related to coordination disturbances, mental health, and criminality, according to a study published online June 12 in The BMJ.
Most Providers Unaware of Online Feedback About Themselves
WEDNESDAY, June 12, 2019 (HealthDay News) — Many health care providers in the United Kingdom have little direct experience with online feedback, rarely encourage it, and often view it as having little value for improving the quality of health services, according to a study published online June 2 in the Journal of Health Services Research & Policy.
Access to Health Care Has Little Impact on Longevity
MONDAY, June 10, 2019 (HealthDay News) — Health care has modest effects on extending life expectancy in the United States, while behavioral and social determinants may have larger effects, according to a review published in the May/June issue of the Annals of Family Medicine.
Irritable Bowel Symptoms Tied to Intestinal, Brain Abnormalities
FRIDAY, June 7, 2019 (HealthDay News) — A greater number of intestinal and brain function abnormalities increases the burden of irritable bowel syndrome (IBS), according to a study recently published in Gastroenterology.
Opioid Safety Initiative Can Decrease Opioid Prescriptions
FRIDAY, June 7, 2019 (HealthDay News) — The Opioid Safety Initiative has been effective for decreasing opioid prescriptions among patients undergoing total knee arthroplasty, according to a study published online May 30 in Anesthesiology.
Rapid Cycling Work Roster Improves Resident Sleep Practices
THURSDAY, June 6, 2019 (HealthDay News) — A rapidly cycling work roster (RCWR) is effective in reducing weekly work hours and the occurrence of >16 consecutive-hour shifts as well as improving sleep duration of resident physicians, according to a study published online May 20 in SLEEP.
Survey Indicates Physician Misconduct Is Underreported
THURSDAY, June 6, 2019 (HealthDay News) — Physician misconduct is being underreported and most Americans do not know where to file a complaint, according to a report published by the Federation of State Medical Boards (FSMB).
Progressive Muscle Relaxation App Tied to Fewer Migraines
THURSDAY, June 6, 2019 (HealthDay News) — Use of a progressive muscle relaxation (PMR) smartphone app is associated with a reduction in headache days among adults with migraines, according to a pilot study published online June 4 in Nature Digital Medicine.
ACP Issues Position on Response to Physician Impairment
MONDAY, June 3, 2019 (HealthDay News) — Providing assistance for physician impairment and rehabilitation is addressed in a position statement issued by the American College of Physicians and published online June 4 in the Annals of Internal Medicine.
FDA Takes Hard Look at CBD
MONDAY, June 3, 2019 (HealthDay News) — The U.S. Food and Drug Administration took a good look at the safety and effectiveness of cannabidiol (CBD) products on Friday, as it weighs how to best regulate the hemp-derived compound going forward.
Copyright © 2019 ScoutNews, LLC. All rights reserved.